🩸

Hematology

19 drugs in pipeline from 10 companies

Drugs in Pipeline

Companies

Upcoming Catalysts

Phase 3 Trials

Upcoming Catalysts

Jun '26

AKBAPhase 3$946M

Erythropoiesis-Stimulating Agent (ESA) Phase 3 Est. Readout

Erythropoiesis-Stimulating Agent (ESA)• Anemia of Chronic Kidney Disease350

Jun 2026~Estimated

CT.gov

00%

days

SNYPDUFA$105.9B

Phase 3✅Approved

FDA PDUFA Date Fitusiran (priority)

Fitusiran• Hemophilia

Jun 16Confirmed

SEC

View all catalysts

Pipeline by Phase

Phase 3

Active Companies

Amgen Inc.

Sanofi

Roche Holding AG

ASTRAZENECA PLC

Novartis AG

Laboratorios Farmaceuticos Rovi, S.A./ADR

Johnson & Johnson

TAKEDA PHARMACEUTICAL CO LTD

1 drugs

BKYI

BIO KEY INTERNATIONAL INC

1 drugs

HMDCF

HUTCHMED (China) Ltd

1 drugs

Related Conditions

bloodhematologyanemiahemophiliathrombocytopeniacoagulationclottingplatelettransfusionsickle cell